Team:UFMG Brazil/Cardbio
From 2013.igem.org
(Difference between revisions)
(→TMAO) |
(→The Problem) |
||
Line 11: | Line 11: | ||
[[File:cardbio_problem_graph3.jpg|700px|thumb|center|Figure 3 - Biomarkers associated with various pathophysiological processes associated with acute myocardial infarction[referencia]]] | [[File:cardbio_problem_graph3.jpg|700px|thumb|center|Figure 3 - Biomarkers associated with various pathophysiological processes associated with acute myocardial infarction[referencia]]] | ||
- | Given | + | Given the importance of this pathophysiological processes, Brazil_UFMG team chose to develop a Genetically Modified Organism able to measure blood serum concentrations of specific ACS biomarkers as a potential prognostic test for this syndrome. |
'''References:''' | '''References:''' |
Revision as of 21:35, 27 September 2013